Canada markets close in 3 hours 34 minutes

NeutriSci International Inc. (NRXCF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0565-0.0123 (-17.88%)
As of 10:12AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.0688
Open0.0565
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0565 - 0.0565
52 Week Range0.0549 - 0.2666
Volume1,001
Avg. Volume4,959
Market Cap9.339M
Beta (5Y Monthly)2.30
PE Ratio (TTM)N/A
EPS (TTM)-0.0110
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    NeutriSci Provides Production Update and Partner Progress

    NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), an innovative technology company developing products, licencing, IP, and technology for B2B partnerships and the nutraceutical industry, is pleased to provide the following update.

  • ACCESSWIRE

    NeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution Partner

    VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company") (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products, licencing IP and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has received an additional order from Tabletz LLC.

  • ACCESSWIRE

    NeutriSci Arranges Strategic Financing with Tabletz and Exercise of Warrants

    VANCOUVER, BC / ACCESSWIRE / September 10, 2021 / NeutriSci International Inc. ("NeutriSci" or the "Company")(TSXV:NU)(OTCQB:NRXCF)(FRA:1N9), an innovative technology company developing products, licencing IP, and technology for B2B partnerships and the nutraceutical industry, is pleased to announce that it has arranged a non-brokered private placement (the "Placement") and the exercise of 4,900,000 warrants, for total combined proceeds of $276,550.